Healthcare -
Biotechnology - NASDAQ - US
$ 4.725
-3.77 %
$ 214 M
Market Cap
-7.05
P/E
YMAB - TAX PROVISION
Tax Provision YMAB - Y-mAbs Therapeutics, Inc.
-146 K
LAST VALUE
-9.22%
2 YEAR CAGR
41.56%
5 YEAR CAGR
0.00%
10 YEAR CAGR